[1]
D. Arko, “UROKINASE PLASMINOGEN ACTIVATOR (uPA) AND PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 (PAI-1) IN BREAST CANCER – CORRELATION WITH TRADITIONAL PROGNOSTIC FACTORS”, Radiol Oncol, vol. 49, no. 4, Jan. 2016.